Ieq Capital, LLC Annexon, Inc. Transaction History
Ieq Capital, LLC
- $32.2 Billion
- Q3 2025
A detailed history of Ieq Capital, LLC transactions in Annexon, Inc. stock. As of the latest transaction made, Ieq Capital, LLC holds 150,322 shares of ANNX stock, worth $429,920. This represents 0.0% of its overall portfolio holdings.
Number of Shares
150,322
Previous 135,797
10.7%
Holding current value
$429,920
Previous $325,000
37.54%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ANNX
# of Institutions
151Shares Held
101MCall Options Held
88.6KPut Options Held
32.5K-
Satter Management Co., L.P.7.41MShares$21.2 Million71.99% of portfolio
-
Bvf Inc San Francisco, CA7MShares$20 Million1.13% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$18.8 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA6.3MShares$18 Million2.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.84MShares$16.7 Million0.0% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $136M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...